Women In Bio, an organization committed to promoting the careers, leadership, and entrepreneurship of women in the life sciences, is hosting a panel discussion focused on the latest breakthroughs in precision oncology. This session will explore the transformative impact these innovations are having on cancer treatment and the acceleration of progress toward more personalized patient care. The discussion offers a compelling look at the future of oncology for anyone with either a professional or personal interest in the field.

The program will provide insights into cutting-edge research, emerging technologies, and the collaborative approaches that are driving personalized care across diverse tumor types. The distinguished panel features industry leaders such as Candy Bermingham of Arcus Biosciences, Kawa Chiu of Abdera Therapeutics, Anne-Renee Hartman of Adela, Manal Mehibel of AbbVie, and Guneet Walia of Johnson and Johnson. This expert lineup ensures an in-depth and practical examination of how top executives and scientists are shaping the next generation of cancer medicine.